229 results on '"Lasnon, Charline"'
Search Results
2. Feasibility of Imaging Small Animals on a 360° Whole-Body Cadmium Zinc Telluride SPECT Camera: a Phantom Study
3. Baseline and early 18F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy
4. Fair play: towards gender equality in nuclear medicine
5. Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT
6. Advances in PET/CT Technology: An Update
7. Baseline and early 18F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy.
8. New PET technologies – embracing progress and pushing the limits
9. Revisiting detection of in-transit metastases in melanoma patients using digital 18F-FDG PET/CT with small-voxel reconstruction
10. Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2
11. A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
12. More fat, less migration: breast density as a predictor of sentinel lymph node non-visualization in breast cancer
13. Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma
14. FRI689 First-line F18-choline PET/CT Versus Tc99m-sestaMIBI SPECT/CT In The Surgical Management Of Primary Hyperparathyroidism: The Multicentre APACH2 Phase III Trial
15. Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy
16. Can someone look after my children while I write this COVID-19 paper?
17. Deep Learning Denoising Improves and Homogenizes Patient [18F]FDG PET Image Quality in Digital PET/CT
18. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
19. Artificial intelligence-based 68Ga-DOTATOC PET denoising for optimizing 68Ge/68Ga generator use throughout its lifetime
20. HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological 18F-FDG anal uptake
21. Comprehensive analysis of the influence of G-CSF on the biodistribution of 18F-FDG in lymphoma patients: insights for PET/CT scheduling
22. Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
23. Reply to: “All that glitters is not gold – new reconstruction methods using Deauville criteria for patient reporting”
24. Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma
25. Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs)
26. EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program
27. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies
28. Fair play: towards gender equality in nuclear medicine
29. Deep Learning Denoising Improves and Homogenizes Patient [ 18 F]FDG PET Image Quality in Digital PET/CT.
30. Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics
31. Prediction of the Presence of Targetable Molecular Alteration(s) with Clinico-Metabolic 18 F-FDG PET Radiomics in Non-Asian Lung Adenocarcinoma Patients
32. Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma
33. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction
34. 18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer
35. Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer
36. Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis
37. Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?
38. NEMA NU 4-Optimized Reconstructions for Therapy Assessment in Cancer Research with the Inveon Small Animal PET/CT System
39. Patient’s weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients
40. Women Authors in Nuclear Medicine Journals: a Survey from 2014 to 2020
41. Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT.
42. Contrast-enhanced small-animal PET/CT in cancer research: strong improvement of diagnostic accuracy without significant alteration of quantitative accuracy and NEMA NU 4–2008 image quality parameters
43. End-of-treatment 18F-FDG PET/CT in diffuse large B cell lymphoma patients: ΔSUV outperforms Deauville score
44. Author Gender Inequality in Medical Imaging Journals and the COVID-19 Pandemic
45. 18F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital
46. Predicting the Presence of Targetable Molecular Alteration(s) With Clinico-metabolic 18F-FDG PET Radiomics in Non-Asian Lung Adenocarcinoma Patients.
47. 18F-FDG PET/CT Versus Diagnostic Contrast-Enhanced CT for Follow-up Of Stage IV Melanoma Patients Treated by Tyrosine Kinase or Immune Checkpoint Inhibitors: Frequency and Management of Discordances Over a 3-Year Period in a University Hospital
48. Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma
49. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients
50. αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.